NCT06191692View on ClinicalTrials.gov

1HP Versus 3HR in the Treatment of Tuberculosis Infection in Vietnam

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2027

Conditions
Tuberculosis Infection
Interventions
DRUG

Isoniazid

This randomized control trial will compare the treatment adherence and safety of the 1HP (Arm B) regimen and standard 3HR (Arm A) regimens for TB infection treatment

DRUG

Rifapentine

This randomized control trial will compare the treatment adherence and safety of the 1HP (Arm B) regimen and standard 3HR (Arm A) regimens for TB infection treatment

DRUG

Rifampicin

This randomized control trial will compare the treatment adherence and safety of the 1HP (Arm B) regimen and standard 3HR (Arm A) regimens for TB infection treatment

Trial Locations (2)

10000

Vietnam National Lung Hospital, Hanoi

Ha Noi Lung Hospital, Hà Nội

All Listed Sponsors
lead

Freundeskreis Für Internationale Tuberkulosehilfe e.V

OTHER